A Study to Evaluate the Pharmacokinetics (Drug Levels and Metabolism), Safety, and Tolerability of BMS-986259 in Participants With Various Levels of Kidney Function
PHASE1
A study to evaluate the drug effect, safety, and tolerability of BMS-986259...
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Preliminary Activity of Tiragolumab in Participants With Relapsed or Refractory Multiple Myeloma or With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
PHASE1
This is a Phase I open-label, multicenter study designed to evaluate the sa...
Status
Terminated
Location
Colorado Blood Cancer Institute (CBCI) at Presbyterian/ St. Luke's Medical Center
A Study to Assess How Much Drug Reaches the Blood When Given From Symbicort pMDI With Spacer Compared to That of Symbicort pMDI Without Spacer in Healthy Volunteers
PHASE1
This study will be conducted to establish the relative bioavailability of b...